Arsene Mekinian Announces New Expert Clinic for Refractory Hemato-Immunologic Diseases
Arsene Mekinian, Professor of Medicine at Sorbonne University, President of Santé Arménie, posted on LinkedIn:
”Dear Brothers, Dear Sisters,
We would like to inform you of the creation of a dedicated specialized consultation within the MINHEMON group, a national FAI2R reference center dedicated to the management of complex hematoimmunological pathologies in person or remotely by video.
This consultation has been specifically set up to accommodate patients with atypical, severe or refractory pictures, particularly when the question arises of an immunological mechanism associated with clonal haemopathy or acquired somatic mutations.
Main indications (non-exhaustive list)
• Myelodysplastic syndromes (MDS/CMML) with inflammatory or autoimmune manifestations
• Chronic lymphocytic leukemia (CLL) complicated by immune dysregulation
• Lymphomas associated with systemic inflammatory or autoimmune manifestations
• Suspected or confirmed VEXAS syndrome
• Severe or refractory systemic autoimmune diseases, especially when hematopoietic clonality or somatic mutation is suspected (UBA1, TET2, DNMT3A, ASXL1, etc.)
Objectives of the dedicated consultation
• Integrated clinical, hematological, immunological and genetic evaluation
• Targeted discussion of specialist examinations (cytometry, myelogram, targeted or expanded NGS)
• Differential diagnosis of borderline or unclassifiable shapes
• Proposal of personalized therapeutic strategies, including innovative options when relevant
Requests for guidance can be sent with:
• a structured clinical summary,
• recent biological assessments,
• the haematological and genetic reports available here will be provided by Dr Vincent Jachiet, Dr Jerome Hadjadj, and Dr Arsène Mekinian”
Stay updated with Hemostasis Today.
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities
-
Feb 22, 2026, 09:12Arun V J։ The Hidden Risks in Every Blood Bag
-
Feb 22, 2026, 08:56Parandzem Khachatryan։ How Hard Is It to Be a Mom, a Wife, a Professor, and a Doctor All at Once?
-
Feb 22, 2026, 08:46Anirban Sen Gupta Presents Bioinspired Platelet Surrogates at MTEC
-
Feb 22, 2026, 08:31Heghine Khachatryan: Advancing Care for Women and Girls with Bleeding Disorders is A Matter of Equity